351 Seminal vesicle invasion: What type of adjuvant treatment should be proposed?
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
European urology / Supplements - 11(2012), 1 vom: Feb., Seite e351 |
| Beteiligte Personen: |
Bastide, C. [VerfasserIn] |
|---|
| BKL: |
|---|
| Umfang: |
1 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1893820076 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1893820076 | ||
| 003 | DE-627 | ||
| 005 | 20230517111957.0 | ||
| 007 | tu | ||
| 008 | 120419s2012 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw120415_1 |
| 035 | |a (DE-627)OLC1893820076 | ||
| 035 | |a (DE-599)GBVOLC1893820076 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a 44.88 |2 bkl | ||
| 100 | 1 | |a Bastide, C. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 351 Seminal vesicle invasion: What type of adjuvant treatment should be proposed? |
| 264 | 1 | |c 2012 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Rossi, D. |4 oth | |
| 700 | 1 | |a Salomon, L. |4 oth | |
| 700 | 1 | |a Mouracade, P. |4 oth | |
| 700 | 1 | |a Rozet, F. |4 oth | |
| 700 | 1 | |a Cathelineau, X. |4 oth | |
| 700 | 1 | |a Forgues, A. |4 oth | |
| 700 | 1 | |a Roupret, M. |4 oth | |
| 700 | 1 | |a Masson-Lecomte, A. |4 oth | |
| 700 | 1 | |a Peyromaure, M. |4 oth | |
| 700 | 1 | |a Rigaud, J. |4 oth | |
| 700 | 1 | |a Larue, S. |4 oth | |
| 700 | 1 | |a Pfister, C. |4 oth | |
| 700 | 1 | |a Bonniol, R. |4 oth | |
| 700 | 1 | |a Patard, J.J. |4 oth | |
| 700 | 1 | |a Bessede, T. |4 oth | |
| 700 | 1 | |a Staerman, F. |4 oth | |
| 700 | 1 | |a Kamdoum, L. |4 oth | |
| 700 | 1 | |a Soulié, M. |4 oth | |
| 700 | 1 | |a Beauval, J.B. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t European urology / Supplements |d Kidlington [u.a.] : Elsevier Science, 2002 |g 11(2012), 1 vom: Feb., Seite e351 |w (DE-627)359573754 |w (DE-600)2097520-X |w (DE-576)103116532 |x 1569-9056 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2012 |g number:1 |g month:02 |g pages:e351 |g extent:1 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_2011 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.88 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 11 |j 2012 |e 1 |c 2 |h e351 |g 1 | ||